ENGAGE AF-TIMI @ was a randomised , double-blind trial in which patients with atrial fibrillation were assigned to warfarin to achieve a target international normalised ratio of @-@ , or to higher-dose ( @ mg ) or lower-dose ( @ mg ) edoxaban once daily .